NO2296686T3 - - Google Patents

Info

Publication number
NO2296686T3
NO2296686T3 NO09751584A NO09751584A NO2296686T3 NO 2296686 T3 NO2296686 T3 NO 2296686T3 NO 09751584 A NO09751584 A NO 09751584A NO 09751584 A NO09751584 A NO 09751584A NO 2296686 T3 NO2296686 T3 NO 2296686T3
Authority
NO
Norway
Application number
NO09751584A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41100519&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2296686(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of NO2296686T3 publication Critical patent/NO2296686T3/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
NO09751584A 2008-05-21 2009-05-21 NO2296686T3 (US20060258714A1-20061116-C00203.png)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5512008P 2008-05-21 2008-05-21
PCT/US2009/044860 WO2009143356A1 (en) 2008-05-21 2009-05-21 Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia

Publications (1)

Publication Number Publication Date
NO2296686T3 true NO2296686T3 (US20060258714A1-20061116-C00203.png) 2014-07-12

Family

ID=41100519

Family Applications (3)

Application Number Title Priority Date Filing Date
NO09751584A NO2296686T3 (US20060258714A1-20061116-C00203.png) 2008-05-21 2009-05-21
NO16165875A NO3085381T3 (US20060258714A1-20061116-C00203.png) 2008-05-21 2009-05-21
NO2019021C NO2019021I1 (no) 2008-05-21 2019-04-30 Desmopressin eller et acetatsalt derav

Family Applications After (2)

Application Number Title Priority Date Filing Date
NO16165875A NO3085381T3 (US20060258714A1-20061116-C00203.png) 2008-05-21 2009-05-21
NO2019021C NO2019021I1 (no) 2008-05-21 2019-04-30 Desmopressin eller et acetatsalt derav

Country Status (16)

Country Link
US (2) US9974826B2 (US20060258714A1-20061116-C00203.png)
EP (5) EP3225249B1 (US20060258714A1-20061116-C00203.png)
JP (5) JP5767103B2 (US20060258714A1-20061116-C00203.png)
CA (1) CA2724653A1 (US20060258714A1-20061116-C00203.png)
DK (5) DK3225250T3 (US20060258714A1-20061116-C00203.png)
ES (5) ES2756706T3 (US20060258714A1-20061116-C00203.png)
HR (4) HRP20161066T1 (US20060258714A1-20061116-C00203.png)
HU (5) HUE046050T2 (US20060258714A1-20061116-C00203.png)
LT (5) LT2712622T (US20060258714A1-20061116-C00203.png)
LU (1) LUC00015I2 (US20060258714A1-20061116-C00203.png)
NO (3) NO2296686T3 (US20060258714A1-20061116-C00203.png)
PL (5) PL2296686T5 (US20060258714A1-20061116-C00203.png)
PT (5) PT3225250T (US20060258714A1-20061116-C00203.png)
SI (4) SI3085381T1 (US20060258714A1-20061116-C00203.png)
TR (2) TR201819189T4 (US20060258714A1-20061116-C00203.png)
WO (1) WO2009143356A1 (US20060258714A1-20061116-C00203.png)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
DK3225250T3 (da) * 2008-05-21 2019-11-04 Ferring Bv Orodispersibel desmopressin til forlængelse af den indledende søvnperiode, som ikke forstyrres af nykturi
US20100286045A1 (en) * 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
WO2015063602A1 (en) * 2013-10-29 2015-05-07 Ferring B.V. Desmopressin and blood glucose
US20210393562A1 (en) * 2018-10-17 2021-12-23 Nippon Chemiphar Co., Ltd. Therapeutic or prophylactic agent for nocturnal polyuria
MX2022012735A (es) * 2020-04-14 2022-11-07 Nippon Chemiphar Co Agente para mejorar la calidad del sueño.
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans

Family Cites Families (147)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH495957A (de) 1966-09-15 1970-09-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids
US4316893A (en) 1975-06-19 1982-02-23 Nelson Research & Development Co. Vehicle composition containing 1-substituted azacycloalkan-2-ones
US3989816A (en) 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4405616A (en) 1975-06-19 1983-09-20 Nelson Research & Development Company Penetration enhancers for transdermal drug delivery of systemic agents
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4285858A (en) 1979-10-30 1981-08-25 Mt. Sinai School Of Medicine Of The City University Of N.Y. Vasopressin analogs
US4263283A (en) 1980-05-16 1981-04-21 Ferring Pharmaceuticals, Inc. Method for prophylaxis and/or treatment of sickle cell disease
GB2111423B (en) 1981-12-02 1985-06-26 Wyeth John & Brother Ltd Making quick-dissolving pills
DE3275121D1 (en) 1981-12-11 1987-02-19 Wyeth John & Brother Ltd Process for preparing solid shaped articles
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
SE8306367L (sv) 1983-11-18 1985-05-19 Ferring Ab Antidiuretiskt verkande farmaceutiskt preparat
US4863737A (en) 1985-05-01 1989-09-05 University Of Utah Compositions and methods of manufacture of compressed powder medicaments
US4588580B2 (en) 1984-07-23 1999-02-16 Alaz Corp Transdermal administration of fentanyl and device therefor
IE60941B1 (en) 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US4878892A (en) 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
US4783450A (en) 1987-04-13 1988-11-08 Warner-Lambert Company Use of commercial lecithin as skin penetration enhancer
DK365389D0 (da) 1989-07-24 1989-07-24 Fertin Lab As Antifungalt tyggegummipraeparat
US5091186A (en) 1989-08-15 1992-02-25 Cygnus Therapeutic Systems Biphasic transdermal drug delivery device
US5527288A (en) 1990-12-13 1996-06-18 Elan Medical Technologies Limited Intradermal drug delivery device and method for intradermal delivery of drugs
TW279133B (US20060258714A1-20061116-C00203.png) 1990-12-13 1996-06-21 Elan Med Tech
SE9101022D0 (sv) 1991-01-09 1991-04-08 Paal Svedman Medicinsk suganordning
US6746678B1 (en) 1991-02-22 2004-06-08 Howard K. Shapiro Method of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with medicaments
AU653026B2 (en) 1991-06-07 1994-09-15 Teikoku Seiyaku Kabushiki Kaisha Physiologically active polypeptide-containing pharmaceutical composition
ATE197126T1 (de) 1991-08-26 2000-11-15 Abbott Lab Verbindungen und methoden zur sublingualen oder buccalen verabreichung von therapeutischen agentien
JP2807346B2 (ja) 1991-12-24 1998-10-08 山之内製薬株式会社 口腔内崩壊製剤及びその製造法
US5298256A (en) 1992-04-28 1994-03-29 Corint, Ltd. Desmopressin buccal patch composition
US5534496A (en) 1992-07-07 1996-07-09 University Of Southern California Methods and compositions to enhance epithelial drug transport
US5343672A (en) 1992-12-01 1994-09-06 Scherer Ltd R P Method for manufacturing freeze dried dosages in a multilaminate blister pack
CA2090738C (en) 1993-02-24 1996-05-21 Hema-Quebec Use of paf
SE9300937L (sv) 1993-03-19 1994-09-20 Anne Fjellestad Paulsen Komposition för oral administrering av peptider
US5434121A (en) * 1993-03-25 1995-07-18 Mitsui Toatsu Chemicals, Incorporated Variety of Drechslera monoceras, weed control compositions containing the same as an effective ingredient and weed control methods using the same
SE501677C2 (sv) 1993-06-18 1995-04-10 Ferring Bv Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel
WO1995001368A1 (en) 1993-06-29 1995-01-12 Ferring B.V. Improved synthesis of cyclic peptides
US5674850A (en) 1993-12-23 1997-10-07 Ferring Ab High purity desmopressin produced in large single batches
US5500413A (en) 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin
US5482931A (en) 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US5985835A (en) 1993-12-23 1999-11-16 Ferring B.V. Desmopressin for nocturia, incontinence and enuresis
CZ282456B6 (cs) 1993-06-29 1997-07-16 Ferring B. V. Kompozice pro nasální podání desmopressinu
EP0736041B1 (en) 1993-11-17 2006-02-08 Athena Neurosciences, Inc. Transparent liquid for encapsulated drug delivery
SE9400918L (sv) 1994-03-18 1995-09-19 Anne Fjellstad Paulsen Stabiliserad komposition för oral administrering av peptider
FR2720003B1 (fr) 1994-05-23 1998-06-26 Samsung Electro Mech Dispositif servant à inciser la peau pour une médication transcutanée.
DE4424800A1 (de) * 1994-07-14 1996-01-18 Philips Patentverwaltung Schaltungsanordnung zum Liefern von Speisespannungen
SE518619C2 (sv) 1994-12-09 2002-10-29 Gs Dev Ab Komposition för reglerad frisättning innehållande monokaproin
GB9502879D0 (en) 1995-02-14 1995-04-05 Oxford Biosciences Ltd Particle delivery
IL113459A (en) 1995-04-23 2000-07-16 Electromagnetic Bracing System Electrophoretic cuff apparatus
US5843016A (en) 1996-03-18 1998-12-01 Physion S.R.L. Electromotive drug administration for treatment of acute urinary outflow obstruction
TW411277B (en) 1996-05-13 2000-11-11 Hisamitsu Pharmaceutical Co Percutaneous tape preparation containing fentanyl
GB9612629D0 (en) 1996-06-17 1996-08-21 Oxford Biosciences Ltd Method for providing dense particle compositions for use in transdermal particle delivery
DK0914178T3 (da) 1996-06-18 2003-04-22 Alza Corp Anordning til forøgelse af transdermal afgivelse eller prøveudtagning af et middel
US5763398A (en) 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin
US5922680A (en) 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
SE9604341D0 (sv) 1996-11-26 1996-11-26 Ferring Bv Hepta-peptide oxytocin analogue
FR2758195B1 (fr) 1997-01-09 1999-02-26 Sgs Thomson Microelectronics Coprocesseur d'arithmetique modulaire comprenant deux circuits de multiplication operant en parallele
US5821230A (en) 1997-04-11 1998-10-13 Ferring Bv GnRH antagonist decapeptides
US5932745A (en) 1997-07-30 1999-08-03 American Home Products Corporation Process for converting propargylic amine-N-oxides to enaminones
US6511974B1 (en) 1997-07-30 2003-01-28 Wyeth Tricyclic vasopressin agonists
US6194407B1 (en) 1997-07-30 2001-02-27 American Home Products Corporation Tricyclic pyrido vasopressin agonists
US5948433A (en) 1997-08-21 1999-09-07 Bertek, Inc. Transdermal patch
US7153845B2 (en) 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US20040018241A1 (en) 1997-09-26 2004-01-29 Noven Pharmaceuticals, Inc. Bioadhesive compositions and methods for topical administration of active agents
US6322532B1 (en) 1998-06-24 2001-11-27 3M Innovative Properties Company Sonophoresis method and apparatus
US6090803A (en) 1998-07-24 2000-07-18 American Home Products Corporation Tricyclic vasopressin agonists
US7138393B2 (en) 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
US6148232A (en) 1998-11-09 2000-11-14 Elecsys Ltd. Transdermal drug delivery and analyte extraction
GB9827292D0 (en) 1998-12-12 1999-02-03 Univ Strathclyde Freeze drying
US6406455B1 (en) 1998-12-18 2002-06-18 Biovalve Technologies, Inc. Injection devices
US20060025387A1 (en) 1998-12-23 2006-02-02 Cytoscan Sciences Llc Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
GB9901819D0 (en) 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions
US6344451B1 (en) 1999-02-04 2002-02-05 American Home Products Pyrrolobenzodiazepine carboxyamide vasopressin agonists
US6297234B1 (en) 1999-02-04 2001-10-02 American Home Products Corporation Arylthiophene vasopressin agonists
US6620807B1 (en) 1999-02-04 2003-09-16 Wyeth Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
US6235900B1 (en) 1999-02-04 2001-05-22 American Home Products Corporation Tricyclic pyridine N-oxides vasopressin agonists
ES2233329T3 (es) 1999-02-15 2005-06-16 Sumitomo Pharmaceuticals Company, Limited Comprimidos que se desintegran rapidamente en la cavidad bucal.
WO2000048669A1 (en) 1999-02-18 2000-08-24 Biovalve Technologies, Inc. Electroactive pore
AR014640A1 (es) 1999-02-23 2001-03-28 Univ Nac Quilmes UNA COMPOSICíoN FARMACÉUTICA INHIBIDORA DE LA DISEMINACIoN METASTÁSICA DURANTE LA CIRUGíA DE UN TUMOR CANCEROSO, UN PROCEDIMENTO DE PREPARACIoN Y UN KIT PARA UNA FORMULACIoN INYECTABLE.
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US7060708B2 (en) 1999-03-10 2006-06-13 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US6210699B1 (en) 1999-04-01 2001-04-03 Watson Pharmaceuticals, Inc. Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity
GB9908014D0 (en) 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US6720001B2 (en) 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
GB2355454A (en) 1999-10-20 2001-04-25 Ferring Bv Antidiuretic agents
US6558695B2 (en) 1999-12-16 2003-05-06 Dermatrends, Inc. Topical and transdermal administration of peptidyl drugs using hydroxide releasing agents as permeation enhancers
GB0000079D0 (en) 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
ATE501751T1 (de) 2000-01-07 2011-04-15 Valeritas Inc Injektionsvorrichtung
US20070032410A1 (en) 2000-01-11 2007-02-08 Atossa Healthcare, Inc. Compositions and methods for the treatment of psychiatric disorders
AT409081B (de) 2000-02-16 2002-05-27 Gebro Pharma Gmbh Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
GB0015601D0 (en) 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents
US6348486B1 (en) 2000-10-17 2002-02-19 American Home Products Corporation Methods for modulating bladder function
NZ525551A (en) 2000-10-26 2005-09-30 Alza Corp Transdermal drug delivery devices having coated microprotrusions
EP2554196B1 (en) 2000-11-30 2018-10-17 Valeritas, Inc. Fluid delivery and measurement systems
JP4434583B2 (ja) 2000-11-30 2010-03-17 バイオバルブ テクノロジーズ インコーポレイテッド 注射システム
US9302903B2 (en) 2000-12-14 2016-04-05 Georgia Tech Research Corporation Microneedle devices and production thereof
AU2002231207A1 (en) 2000-12-21 2002-07-01 Biovalve Technologies, Inc. Microneedle array systems
CN101524339A (zh) 2001-03-16 2009-09-09 阿尔扎公司 施用芬太尼的经皮贴剂
WO2002083145A1 (en) 2001-04-12 2002-10-24 Wyeth N-biphenylcarbonyl- and n-phenylpyridylcarbonyl substituted bi- and tricyclic azepines and diazepines as vasopressing agonists
EP1381608B1 (en) 2001-04-12 2007-10-10 Wyeth Cyclohexylphenyl vasopressin agonists
US7022699B2 (en) 2001-04-12 2006-04-04 Wyeth Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
US7615234B2 (en) 2001-09-11 2009-11-10 Glide Pharmaceutical Technologies Limited Drug delivery technology
GB2391480B (en) 2002-08-05 2007-02-28 Caretek Medical Ltd Drug delivery system
PL206246B1 (pl) 2001-09-13 2010-07-30 Kissei Pharmaceutical Co Ltdkissei Pharmaceutical Co Ltd Pochodna hydroksynorefedryny, jej kryształy, kompozycja farmaceutyczna, lek oraz zastosowanie
US6723077B2 (en) 2001-09-28 2004-04-20 Hewlett-Packard Development Company, L.P. Cutaneous administration system
US6893655B2 (en) 2001-10-09 2005-05-17 3M Innovative Properties Co. Transdermal delivery devices
MY148466A (en) 2001-10-26 2013-04-30 Merck Frosst Canada Ltd Granule formulation
JP4075064B2 (ja) 2001-11-16 2008-04-16 アステラス製薬株式会社 ４，４−ジフルオロ−１，２，３，４−テトラヒドロ−５ｈ−１−ベンゾアゼピン誘導体又はその塩
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
DE60307082T4 (de) * 2002-05-07 2015-04-30 Ferring B.V. In der mundhöhle dispergierbare phamarzeutische zusammensetzung mit desmopressin
US6945952B2 (en) 2002-06-25 2005-09-20 Theraject, Inc. Solid solution perforator for drug delivery and other applications
CA2516547A1 (en) 2002-09-30 2004-04-15 Alza Corporation Drug delivery device having coated microprojections incorporating vasoconstrictors
KR101060629B1 (ko) 2002-10-09 2011-08-31 도레이 카부시키가이샤 빈뇨 혹은 요실금의 치료 또는 예방제 및 함질소 환상치환기를 갖는 몰피난 유도체
US7383084B2 (en) 2002-10-31 2008-06-03 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
EP1428526A1 (en) 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Formulation for fast dissolution of lipophilic compounds
DE10259934B3 (de) 2002-12-20 2004-10-14 H.C. Starck Gmbh Verfahren zur Herstellung von Formteilen aus Niob oder Tantal durch elektrochemisches Ätzen und so erhältliche Formteile
AR042815A1 (es) 2002-12-26 2005-07-06 Alza Corp Dispositivo de suministro de agente activo que tiene miembros compuestos
KR100882154B1 (ko) 2003-04-28 2009-02-06 아스텔라스세이야쿠 가부시키가이샤 4,4-디플루오로-1,2,3,4-테트라하이드로-5ｈ-1-벤즈아제핀 유도체 또는 이의 염 및 이를 포함하는 의약 조성물
US20060193825A1 (en) 2003-04-29 2006-08-31 Praecis Phamaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US7094545B2 (en) 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
DK1638468T3 (da) 2003-06-30 2007-12-17 Alza Corp Fremgangsmåde til coating af hudpiercingmikrofremspring
CN1826099B (zh) 2003-07-25 2010-06-09 凡林有限公司 固体剂型药物组合物及其制造方法
ES2243840T3 (es) 2003-07-25 2005-12-01 Ferring B.V. Composicion farmaceutica de desmopresina como forma farmaceutica solida de dosificacion y metodo para la fabricacion de la misma.
US6930932B2 (en) 2003-08-27 2005-08-16 Hewlett-Packard Development Company, L.P. Data signal reception latch control using clock aligned relative to strobe signal
WO2005042054A2 (en) 2003-10-24 2005-05-12 Alza Corporation Pretreatment method and system for enhancing transdermal drug delivery
WO2005041871A2 (en) 2003-10-24 2005-05-12 Alza Corporation Apparatus and method for enhancing transdermal drug delivery
JP4682144B2 (ja) 2003-10-31 2011-05-11 アルザ・コーポレーシヨン 微小突起列のための自己−作動性アプリケーター
WO2005046707A1 (en) * 2003-11-10 2005-05-26 Fein Seymour H Pharmaceutical compositions including low dosages of desmopressin
ES2260563T3 (es) 2003-11-13 2006-11-01 Ferring B.V. Paquete de blister y forma farmaceutica solida para ello.
PT1550439E (pt) 2003-12-29 2006-06-30 Ferring Bv Metodo para a preparacao de uma forma solida de dosagem de desmopressina
US7018653B2 (en) 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
AU2004314416A1 (en) 2004-01-09 2005-08-04 Alza Corporation Frequency assisted transdermal agent delivery method and system
ES2572811T3 (es) 2004-09-09 2016-06-02 Yeda Research And Development Co., Ltd. Mezclas de polipéptidos, composiciones que las contienen y procedimientos para obtener los mismos, y usos de los mismos
US7097776B2 (en) 2004-10-22 2006-08-29 Hewlett-Packard Development Company, L.P. Method of fabricating microneedles
US20060093658A1 (en) 2004-10-26 2006-05-04 Gayatri Sathyan Apparatus and method for transdermal delivery of desmopressin
CN100339081C (zh) 2004-11-10 2007-09-26 范敏华 一种氯雷他定口腔崩解片剂的制备方法
US7180274B2 (en) 2004-12-10 2007-02-20 Aimtron Technology Corp. Switching voltage regulator operating without a discontinuous mode
MX2007013021A (es) 2005-04-22 2008-01-11 Wyeth Corp Derivados de benzofuranil-alcanamina y usos de los mismos como agonistas de 5-ht2c.
US7856263B2 (en) 2005-04-22 2010-12-21 Travanti Pharma Inc. Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis
CN101203505A (zh) 2005-04-22 2008-06-18 惠氏公司 苯并二氢吡喃和苯并吡喃衍生物及其用途
AR056979A1 (es) 2005-04-22 2007-11-07 Wyeth Corp Derivados de dihidrobenzofuranos y usos de los mismos
TW200718692A (en) 2005-04-22 2007-05-16 Wyeth Corp Dihydrobenzofuran derivatives and uses thereof
GT200600159A (es) 2005-04-22 2007-03-14 Derivados benzodioxano y benzodioxolano y usos de los mismos
MX2007013064A (es) 2005-04-24 2008-01-16 Wyeth Corp Metodo para modular la funcion de la vejiga.
WO2006138719A2 (en) 2005-06-17 2006-12-28 Georgia Tech Research Corporation Coated microstructures and method of manufacture thereof
US20080195035A1 (en) 2005-06-24 2008-08-14 Frederickson Franklyn L Collapsible Patch and Method of Application
WO2007083323A2 (en) 2006-01-23 2007-07-26 Panacea Biotec Limited. Modified release oral dosage form comprising desmopressin
CA2584456C (en) 2006-03-02 2008-07-22 Ferring International Center S.A. Composition comprising desmopressin
WO2007127976A2 (en) 2006-05-01 2007-11-08 Georgia Tech Research Corporation Particle based molding
WO2009021007A1 (en) 2007-08-06 2009-02-12 Serenity Pharmaceuticals Corporation Methods and devices for desmopressin drug delivery
DK3225250T3 (da) * 2008-05-21 2019-11-04 Ferring Bv Orodispersibel desmopressin til forlængelse af den indledende søvnperiode, som ikke forstyrres af nykturi

Also Published As

Publication number Publication date
EP3225249A1 (en) 2017-10-04
ES2462465T3 (es) 2014-05-22
ES2462465T5 (es) 2018-02-28
JP2016196514A (ja) 2016-11-24
EP3225250B1 (en) 2019-08-21
JP5767103B2 (ja) 2015-08-19
JP6506821B2 (ja) 2019-04-24
SI2712622T1 (sl) 2016-10-28
NO2019021I1 (no) 2019-04-30
JP2015120761A (ja) 2015-07-02
HUE041370T2 (hu) 2019-05-28
EP2296686B1 (en) 2014-02-12
HUS1900024I1 (hu) 2019-05-28
TR201807224T4 (tr) 2018-06-21
EP2712622A1 (en) 2014-04-02
PL3085381T3 (pl) 2018-09-28
PT2712622T (pt) 2016-10-13
EP3225249B1 (en) 2018-11-07
WO2009143356A1 (en) 2009-11-26
PT3085381T (pt) 2018-05-18
ES2596435T3 (es) 2017-01-09
US20090291880A1 (en) 2009-11-26
EP3225250A1 (en) 2017-10-04
PL2712622T3 (pl) 2017-01-31
EP3085381B1 (en) 2018-04-18
ES2710454T3 (es) 2019-04-25
US9974826B2 (en) 2018-05-22
HRP20161066T1 (hr) 2016-10-21
PL2296686T5 (pl) 2018-06-29
HUE046050T2 (hu) 2020-01-28
NO3085381T3 (US20060258714A1-20061116-C00203.png) 2018-09-15
JP2011520980A (ja) 2011-07-21
PL2296686T3 (pl) 2014-07-31
JP2019123739A (ja) 2019-07-25
EP2296686A1 (en) 2011-03-23
PL3225249T3 (pl) 2019-05-31
DK3085381T3 (en) 2018-05-28
ES2756706T3 (es) 2020-04-27
LT3225249T (lt) 2019-01-10
JP6836618B2 (ja) 2021-03-03
LT3225250T (lt) 2019-11-11
PT2296686E (pt) 2014-05-23
HRP20190114T1 (hr) 2019-03-08
JP2018035198A (ja) 2018-03-08
ES2677548T3 (es) 2018-08-03
DK2296686T4 (en) 2018-01-02
DK3225249T3 (en) 2019-02-25
LUC00015I1 (US20060258714A1-20061116-C00203.png) 2017-04-19
LUC00015I2 (US20060258714A1-20061116-C00203.png) 2017-06-19
JP6001121B2 (ja) 2016-10-05
LTC2712622I2 (lt) 2020-02-10
SI3225250T1 (sl) 2019-11-29
HUE039013T4 (hu) 2019-08-28
HUE030409T2 (en) 2017-05-29
CA2724653A1 (en) 2009-11-26
LTPA2017001I1 (lt) 2017-02-10
DK2296686T3 (da) 2014-05-12
DK2712622T3 (en) 2016-09-12
HRP20191854T1 (hr) 2019-12-27
PL3225250T3 (pl) 2020-02-28
SI3225249T1 (sl) 2019-02-28
JP6258424B2 (ja) 2018-01-10
HRP20180774T1 (hr) 2018-08-10
HUE039013T2 (hu) 2018-12-28
SI3085381T1 (en) 2018-06-29
DK3225250T3 (da) 2019-11-04
EP2712622B1 (en) 2016-07-13
US20180250357A1 (en) 2018-09-06
LT3085381T (lt) 2018-06-11
EP3085381A1 (en) 2016-10-26
EP2296686B2 (en) 2017-11-01
PT3225249T (pt) 2019-01-17
PT3225250T (pt) 2019-10-15
LT2712622T (lt) 2016-09-26
TR201819189T4 (tr) 2019-01-21

Similar Documents

Publication Publication Date Title
BRPI0917573A2 (US20060258714A1-20061116-C00203.png)
BRPI0918697A2 (US20060258714A1-20061116-C00203.png)
BRPI0917525A2 (US20060258714A1-20061116-C00203.png)
BRPI0920750A2 (US20060258714A1-20061116-C00203.png)
BRPI0919470A2 (US20060258714A1-20061116-C00203.png)
BRPI0922455A2 (US20060258714A1-20061116-C00203.png)
BRPI0917618A8 (US20060258714A1-20061116-C00203.png)
BRPI0923734A2 (US20060258714A1-20061116-C00203.png)
BRPI0912727A2 (US20060258714A1-20061116-C00203.png)
BRPI0910485A2 (US20060258714A1-20061116-C00203.png)
BRPI0922669A2 (US20060258714A1-20061116-C00203.png)
BRPI0914750A2 (US20060258714A1-20061116-C00203.png)
BRPI0912462A2 (US20060258714A1-20061116-C00203.png)
BRPI0915616A2 (US20060258714A1-20061116-C00203.png)
BRPI0919811A2 (US20060258714A1-20061116-C00203.png)
BRPI0920914A2 (US20060258714A1-20061116-C00203.png)
BRPI0922550A2 (US20060258714A1-20061116-C00203.png)
BRPI0916284A2 (US20060258714A1-20061116-C00203.png)
BRPI0913605A2 (US20060258714A1-20061116-C00203.png)
BRPI0911617A2 (US20060258714A1-20061116-C00203.png)
BRPI0914852A2 (US20060258714A1-20061116-C00203.png)
BRPI0910572A2 (US20060258714A1-20061116-C00203.png)
CH2347250H2 (US20060258714A1-20061116-C00203.png)
BRPI0914820A2 (US20060258714A1-20061116-C00203.png)
NO2296686T3 (US20060258714A1-20061116-C00203.png)